CEVEC CEO talks US deals to expand business

Frank Ubags, CEO of CEVEC—a company offering industrial scale production of viral vectors for gene therapy firms—speaks with Scrip's Lucie Ellis about the types of deals the platform technology company is seeking and what is coming up for CEVEC in 2016. He also highlights a deal the company is looking to solidify in the coming weeks that will expand its activities in the US.
Interviewer: Lucie Ellis – Reporter, Pharma Intelligence In Vivo/Pink Sheet/Scrip
Interviewee: Frank Ubags – CEO, CEVEC Pharmaceuticals GmbH